---
schema_version: "secwatch.filing_event.v1"
accession: "0001156039-25-000139"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2025-11-10T23:59:59+00:00"
generated_at: "2026-05-16T22:15:16.591326+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Elevance Health reaffirms FY2025 EPS guidance of $24.70 ($30.00 adj.) and 90.0% benefit expense ratio

## Summary
- Full-year 2025 GAAP EPS expected ~$24.70, including ~$5.30/sh net unfavorable items.
- Adjusted EPS guidance unchanged at ~$30.00 per diluted share.
- Full-year 2025 benefit expense ratio reaffirmed at approximately 90.0%.
- Reaffirmation reflects current view on market conditions, operational performance, and regulatory landscape.
- Guidance does not include adjustment items beyond those reported in Q3 2025 earnings.

## SEC filing metadata
- accession: 0001156039-25-000139
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2025-11-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000139/0001156039-25-000139-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000139/elv-20251110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001156039-25-000139
- JSON: https://secwatch.observer/filing/0001156039-25-000139.json
- Plain text: https://secwatch.observer/filing/0001156039-25-000139.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.